IRBESARTAN HCT
IRBESARTAN HCT
Approved
DIN Number
02385325
Drug Class
Human
Market Date
Jun 12, 2012
Company
HC
sivem pharmaceuticals ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02385325
AIG Number0240086002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09DA04 IRBESARTAN AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification40:28.20
Health Canada Classification
ACTIVE INGREDIENTS (2)
HYDROCHLOROTHIAZIDEActive
Strength: 12.5 MG
Monograph: HYDROCHLOROTHIAZIDE
IRBESARTANActive
Strength: 300 MG
Monograph: IRBESARTAN